Skip to content

COMPARATIVE EVALUATION OF CORONALLY ADVANCED FLAP WITH MUCODERM AND CORONALLY ADVANCED FLAP ALONE IN MANAGEMENT OF GINGIVAL RECESSION - A CLINICAL STUDY

COMPARATIVE EVALUATION OF CORONALLY ADVANCED FLAP WITH MUCODERM AND CORONALLY ADVANCED FLAP ALONE IN MANAGEMENT OF GINGIVAL RECESSION - A CLINICAL STUDY - COMPARATIVE EVALUATION OF CORONALLY ADVANCED FLAP WITH MUCODERM AND CORONALLY ADVANCED FLAP ALONE IN MANAGEMENT OF GINGIVAL RECESSION - A CLINICAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058041
Enrollment
20
Registered
2025-06-02
Start date
2023-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession is a common periodontal condition that leads to aesthetic concerns and potential tooth sensitivity. Various surgical approaches have been developed to manage this condition, with the Coronally Advanced Flap (CAF) being one of the most frequently employed techniques. Recent advances have introduced Mucoderm, a Collagen Matrix, to enhance outcomes when combined with CAF. However, the comparative efficacy of CAF alone versus CAF combined with Mucoderm remains under-explored.

Interventions

CORONALLY ADVANCED FLAP AND MUCODERM FOR ROOT COVERAGE CORONALLY ADVANCED FLAP ALONE FOR ROOT COVERAGE

Sponsors

CSI COLLEGE OF DENTAL SCIENCES AND RESEARCH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Presence of Gingival Recession of Miller Class I or Class II. Age of 18 to 40 years old. Systemically healthy with no contraindications for periodontal surgery. Absence of clinical signs of active periodontal disease.

Exclusion criteria

Exclusion criteria: Systemic disease with compromised healing potential or infectious disease. Usage of medication known to affect gingival conditions (hyperplasia) or to interfere with healing (steroids). Pregnant or Lactating mothers. Non-vital teeth, caries, prosthetic crowns or restorations involving the cemento-enamel junction area. Tobacco smoking, drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
To compare and evaluate the changes in Clinical Parameters such as Recession Depth (RD), Gingival Thickness (GT) and Width of Attached Gingiva (WAG) among patients undergoing surgical treatment with Coronally Advanced Flap with Mucoderm (Test group) and Coronally Advanced Flap alone (Control group) at baseline, 1 month and 3 months post-treatment.

Secondary

MeasureTime frame
To assess Patient-Reported Outcome Measures (PROMs) using Visual Analogue Scale (VAS) scores at 2 weeks and Questionnaires (patient satisfaction) at 3 months, and Professional Esthetic Evaluation using Root Coverage Esthetic Score (RES) at 3 months, among patients undergoing surgical treatment with Coronally Advanced Flap with Mucoderm (Test group) and Coronally Advanced Flap alone (Control group). To compare and evaluate the changes in Clinical Parameters especially Probing Pocket Depth (PPD) and Clinical Attachment Level (CAL) among patients undergoing surgical treatment with Coronally Advanced Flap with Mucoderm (Test group) and Coronally Advanced Flap alone (Control group) at baseline, 1 month and 3 months post-treatment.

Countries

Asia(except Japan)

Contacts

Public ContactJANE MAANSINGH

CSI COLLEGE OF DENTAL SCIENCES AND RESEARCH DEPARTMENT OF PERIODONTICS AND IMPLANT DENTISTRY

janecsiperio@gmail.com+919843110466

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026